𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Recombinant antibody constructs in cancer therapy

✍ Scribed by Peter J Hudson

Publisher
Elsevier Science
Year
1999
Tongue
English
Weight
170 KB
Volume
11
Category
Article
ISSN
0952-7915

No coin nor oath required. For personal study only.

✦ Synopsis

CDR complementarity-determining region C H heavy-chain C-region FACS florescence-activated cell sorters FDA Food and Drug Administration IFOM imaging figure of merit PCR polymerase chain reaction scFv

πŸ“œ SIMILAR VOLUMES

Recombinant polyclonal antibodies for ca
Recombinant polyclonal antibodies for cancer therapy
✍ Jacqueline Sharon; Meredith A. Liebman; Brent R. Williams πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 178 KB

## Abstract Although monoclonal antibodies are increasingly used for cancer therapy, remissions are only temporary due to emergence of tumor cell escape variants that are no longer affected by the antibody. The emergence of escape variants could be minimized by multi‐targeting of tumor cells with p

Monoclonal antibodies in cancer therapy
Monoclonal antibodies in cancer therapy
✍ Gert RiethmΓΌller; Elena Schneider-GΓ€dicke; Judith P. Johnson πŸ“‚ Article πŸ“… 1993 πŸ› Elsevier Science 🌐 English βš– 1022 KB

A review of the clinical trials of antibody based cancer therapies reveals that this approach can, in rare cases, induce complete remissions in individual patients with cancer. Since these trials have usually involved patients with large tumor masses, tumor cell inaccessibility is probably a major r

Monoclonal antibodies in cancer therapy
Monoclonal antibodies in cancer therapy
✍ Gruben, Rudolf ;Holz, Elena ;RiethmοΏ½ller, Gert πŸ“‚ Article πŸ“… 1996 πŸ› Springer 🌐 English βš– 590 KB